Embecta Corp. (EMBC)
After hours:
| Previous close | 10.40 |
| Open | 10.40 |
| Bid | 10.28 x 200 |
| Ask | 10.32 x 200 |
| Day's range | 10.29 - 10.58 |
| 52-week range | 9.93 - 32.00 |
| Volume | |
| Avg. volume | 433,509 |
| Market cap | 593.638M |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | 10.74 |
| EPS (TTM) | 0.96 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | 0.60 (5.82%) |
| Ex-dividend date | 27 Feb 2024 |
| 1y target est | 16.50 |
GlobeNewswireembecta to Report Fiscal Second Quarter 2024 Financial Results
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, May 9, 2024. Those who would like to participate may access the live webcast here, or access the teleconference here. The live
- GlobeNewswire
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorship of a symposium at the Advanced Technologies & Treatments for Diabetes (ATTD) international conference. This event is scheduled for Wednesday, March 6, at 10:40 a.m. Eastern Standard Time / 14:40 Central European Time. Additionally, six embecta-sponsored abstracts focusing on injection and insulin
Simply Wall St.Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15
Embecta Corp.'s ( NASDAQ:EMBC ) investors are due to receive a payment of $0.15 per share on 15th of March. This makes...
